Click here to get full coverage on Why (GHRS) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Why (GHRS) Price Action Is Critical for Tactical Trading  Stock Traders Daily

Why (GHRS) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Click here to get full coverage on Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - Yahoo Finance

Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet  Yahoo Finance

Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - Yahoo Finance

Click here to get full coverage on Shorts Report: Why GHRS stock is favored by top institutions - Trade Risk Assessment & Safe Entry Point Alerts - moha.gov.vn

Shorts Report: Why GHRS stock is favored by top institutions - Trade Risk Assessment & Safe Entry Point Alerts  moha.gov.vn

Shorts Report: Why GHRS stock is favored by top institutions - Trade Risk Assessment & Safe Entry Point Alerts - moha.gov.vn

Click here to get full coverage on We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth - Sahm

We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth  Sahm

We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth - Sahm

Click here to get full coverage on Needham Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Needham Initiates Coverage of GH Research (GHRS) with Buy Recommendation  Nasdaq

Needham Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Click here to get full coverage on New Analyst Forecast: $GHRS Given $19.0 Price Target - Quiver Quantitative

New Analyst Forecast: $GHRS Given $19.0 Price Target  Quiver Quantitative

New Analyst Forecast: $GHRS Given $19.0 Price Target - Quiver Quantitative

Click here to get full coverage on No treatment-related SAEs: GH Research 6‑Month GH001 safety & psychoactive data for TRD at ECNP 2025 - Stock Titan

No treatment-related SAEs: GH Research 6‑Month GH001 safety & psychoactive data for TRD at ECNP 2025  Stock Titan

No treatment-related SAEs: GH Research 6‑Month GH001 safety & psychoactive data for TRD at ECNP 2025 - Stock Titan

Click here to get full coverage on GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewswire

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates  GlobeNewswire

GH Research Reports Third Quarter 2025 Financial Results and Provides Business Updates - GlobeNewswire

Click here to get full coverage on Cantor Fitzgerald Initiates Coverage of GH Research (GHRS) With Overweight Rating - Insider Monkey

Cantor Fitzgerald Initiates Coverage of GH Research (GHRS) With Overweight Rating  Insider Monkey

Cantor Fitzgerald Initiates Coverage of GH Research (GHRS) With Overweight Rating - Insider Monkey

Click here to get full coverage on GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial - Yahoo Finance

GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial  Yahoo Finance

GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial - Yahoo Finance

Click here to get full coverage on Understanding Momentum Shifts in (GHRS) - Stock Traders Daily

Understanding Momentum Shifts in (GHRS)  Stock Traders Daily

Understanding Momentum Shifts in (GHRS) - Stock Traders Daily

Click here to get full coverage on Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation  Nasdaq

Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Click here to get full coverage on GH Research Announces Global Pivotal Program Plans and Further Development Updates - GlobeNewswire

GH Research Announces Global Pivotal Program Plans and Further Development Updates  GlobeNewswire

GH Research Announces Global Pivotal Program Plans and Further Development Updates - GlobeNewswire

Click here to get full coverage on GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress | GHRS Stock News - Quiver Quantitative

GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress | GHRS Stock News  Quiver Quantitative

GH Research PLC Announces Acceptance of Presentation and Posters on GH001 for Treatment-Resistant Depression at ECNP Congress | GHRS Stock News - Quiver Quantitative

Click here to get full coverage on Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade - Yahoo Finance

Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade  Yahoo Finance

Wall Street Analysts Believe GH Research (GHRS) Could Rally 107.25%: Here's is How to Trade - Yahoo Finance

Click here to get full coverage on We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth - Yahoo Finance

We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth  Yahoo Finance

We Think GH Research (NASDAQ:GHRS) Can Easily Afford To Drive Business Growth - Yahoo Finance

Click here to get full coverage on Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025 - Yahoo Finance

Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025  Yahoo Finance

Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025 - Yahoo Finance

Click here to get full coverage on Aug Sectors: Why GHRS stock is popular among millennials - July 2025 PreEarnings & Risk Managed Investment Strategies - Улправда

Aug Sectors: Why GHRS stock is popular among millennials - July 2025 PreEarnings & Risk Managed Investment Strategies  Улправда

Aug Sectors: Why GHRS stock is popular among millennials - July 2025 PreEarnings & Risk Managed Investment Strategies - Улправда

Click here to get full coverage on Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025 - Yahoo Finance

Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025  Yahoo Finance

Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025 - Yahoo Finance

Click here to get full coverage on GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat insider, and their holdings increased by 31% last week - Yahoo Finance

GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat insider, and their holdings increased by 31% last week  Yahoo Finance

GH Research PLC's (NASDAQ:GHRS) Top Key Executive Florian Schonharting is the most upbeat insider, and their holdings increased by 31% last week - Yahoo Finance

Click here to get full coverage on Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga

Depression-Focused GH Research Shares Could See Significant Upside: Analyst  Benzinga

Depression-Focused GH Research Shares Could See Significant Upside: Analyst - Benzinga

Click here to get full coverage on GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025  Yahoo Finance

GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025 - Yahoo Finance

Click here to get full coverage on GH Research reports progress on FDA engagement for GH001 IND - Investing.com

GH Research reports progress on FDA engagement for GH001 IND  Investing.com

GH Research reports progress on FDA engagement for GH001 IND - Investing.com

Click here to get full coverage on Citizens JMP Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛

Citizens JMP Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39  富途牛牛

Citizens JMP Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $39 - 富途牛牛

Click here to get full coverage on Why GHRS stock is popular among millennials - July 2025 Decliners & Real-Time Buy Zone Alerts - Улправда

Why GHRS stock is popular among millennials - July 2025 Decliners & Real-Time Buy Zone Alerts  Улправда

Why GHRS stock is popular among millennials - July 2025 Decliners & Real-Time Buy Zone Alerts - Улправда

Click here to get full coverage on GH Research PLC Submits Complete Response to FDA's Clinical Hold on GH001 IND | GHRS Stock News - Quiver Quantitative

GH Research PLC Submits Complete Response to FDA's Clinical Hold on GH001 IND | GHRS Stock News  Quiver Quantitative

GH Research PLC Submits Complete Response to FDA's Clinical Hold on GH001 IND | GHRS Stock News - Quiver Quantitative

Click here to get full coverage on Why GHRS stock is popular among millennials - July 2025 Snapshot & Weekly High Return Stock Forecasts - Улправда

Why GHRS stock is popular among millennials - July 2025 Snapshot & Weekly High Return Stock Forecasts  Улправда

Why GHRS stock is popular among millennials - July 2025 Snapshot & Weekly High Return Stock Forecasts - Улправда

Click here to get full coverage on Portfolio Shifts: What catalysts could drive GHRS stock higher - 2025 Earnings Surprises & Stock Timing and Entry Methods - Улправда

Portfolio Shifts: What catalysts could drive GHRS stock higher - 2025 Earnings Surprises & Stock Timing and Entry Methods  Улправда

Portfolio Shifts: What catalysts could drive GHRS stock higher - 2025 Earnings Surprises & Stock Timing and Entry Methods - Улправда

Click here to get full coverage on GH Research Reports Q3 2025 Financial Results - TipRanks

GH Research Reports Q3 2025 Financial Results  TipRanks

GH Research Reports Q3 2025 Financial Results - TipRanks

Click here to get full coverage on GH Research Responds to FDA Clinical Hold on Depression Treatment GH001 Ahead of Schedule - Yahoo Finance

GH Research Responds to FDA Clinical Hold on Depression Treatment GH001 Ahead of Schedule  Yahoo Finance

GH Research Responds to FDA Clinical Hold on Depression Treatment GH001 Ahead of Schedule - Yahoo Finance

Click here to get full coverage on GH Research Unveils Pivotal Program Plans Amidst Promising Trial Results - TipRanks

GH Research Unveils Pivotal Program Plans Amidst Promising Trial Results  TipRanks

GH Research Unveils Pivotal Program Plans Amidst Promising Trial Results - TipRanks

Click here to get full coverage on GH Research PLC Provides Update on GH001 IND Response and Phase 2b Clinical Trial Results in Treatment-Resistant Depression - Quiver Quantitative

GH Research PLC Provides Update on GH001 IND Response and Phase 2b Clinical Trial Results in Treatment-Resistant Depression  Quiver Quantitative

GH Research PLC Provides Update on GH001 IND Response and Phase 2b Clinical Trial Results in Treatment-Resistant Depression - Quiver Quantitative

Click here to get full coverage on Is GHRS stock cheap at current valuation - Sell Signal & Safe Entry Zone Identification - Улправда

Is GHRS stock cheap at current valuation - Sell Signal & Safe Entry Zone Identification  Улправда

Is GHRS stock cheap at current valuation - Sell Signal & Safe Entry Zone Identification - Улправда

Click here to get full coverage on GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule - GlobeNewswire

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule  GlobeNewswire

GH Research Submits Complete IND Hold Response to FDA Ahead of Schedule - GlobeNewswire

Click here to get full coverage on Can GHRS stock weather global recession - Market Weekly Review & Low Risk High Reward Ideas - Улправда

Can GHRS stock weather global recession - Market Weekly Review & Low Risk High Reward Ideas  Улправда

Can GHRS stock weather global recession - Market Weekly Review & Low Risk High Reward Ideas - Улправда

Click here to get full coverage on Cantor Fitzgerald reiterates Overweight rating on GH Research stock - Investing.com

Cantor Fitzgerald reiterates Overweight rating on GH Research stock  Investing.com

Cantor Fitzgerald reiterates Overweight rating on GH Research stock - Investing.com

Click here to get full coverage on GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates  Yahoo Finance

GH Research Reports First Quarter 2025 Financial Results and Provides Business Updates - Yahoo Finance

Click here to get full coverage on Profit Recap: Will GHRS stock beat EPS estimates - Weekly Profit Analysis & Reliable Breakout Forecasts - Улправда

Profit Recap: Will GHRS stock beat EPS estimates - Weekly Profit Analysis & Reliable Breakout Forecasts  Улправда

Profit Recap: Will GHRS stock beat EPS estimates - Weekly Profit Analysis & Reliable Breakout Forecasts - Улправда

Click here to get full coverage on This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday  Benzinga

This Monopar Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Click here to get full coverage on GH Research reports breakthrough in depression treatment - Investing.com

GH Research reports breakthrough in depression treatment  Investing.com

GH Research reports breakthrough in depression treatment - Investing.com

Click here to get full coverage on GH Research Stock Soars: Promising Developments - StocksToTrade

GH Research Stock Soars: Promising Developments  StocksToTrade

GH Research Stock Soars: Promising Developments - StocksToTrade

Click here to get full coverage on GH Research to Engage at Stifel 2025 Healthcare Conference - TipRanks

GH Research to Engage at Stifel 2025 Healthcare Conference  TipRanks

GH Research to Engage at Stifel 2025 Healthcare Conference - TipRanks

Click here to get full coverage on GH Research Announces Pricing of $150 Million Public Offering - GlobeNewswire

GH Research Announces Pricing of $150 Million Public Offering  GlobeNewswire

GH Research Announces Pricing of $150 Million Public Offering - GlobeNewswire

Click here to get full coverage on GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates  GlobeNewswire

GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire

Click here to get full coverage on GH Research Announces Proposed Public Offering - Yahoo Finance

GH Research Announces Proposed Public Offering  Yahoo Finance

GH Research Announces Proposed Public Offering - Yahoo Finance

Click here to get full coverage on These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Stocktwits

These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week  Stocktwits

These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week - Stocktwits

Click here to get full coverage on Anthropology Graduate Students Triumph at the GHRS - William & Mary

Anthropology Graduate Students Triumph at the GHRS  William & Mary

Anthropology Graduate Students Triumph at the GHRS - William & Mary

Click here to get full coverage on Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect?  Yahoo Finance

Can GH Research PLC (GHRS) Climb 488.72% to Reach the Level Wall Street Analysts Expect? - Yahoo Finance

Click here to get full coverage on GH Research (GHRS) - Zacks Investment Research

GH Research (GHRS)  Zacks Investment Research

GH Research (GHRS) - Zacks Investment Research

Click here to get full coverage on GHRS Stock Price and Chart — NASDAQ:GHRS - TradingView — Track All Markets

GHRS Stock Price and Chart — NASDAQ:GHRS  TradingView — Track All Markets

GHRS Stock Price and Chart — NASDAQ:GHRS - TradingView — Track All Markets

Click here to get full coverage on 3 Psychedelic Stocks to Ride to the Moon and Beyond - InvestorPlace

3 Psychedelic Stocks to Ride to the Moon and Beyond  InvestorPlace

3 Psychedelic Stocks to Ride to the Moon and Beyond - InvestorPlace

Click here to get full coverage on GHRS - Gh Research Plc Latest Stock News & Market Updates - Stock Titan

GHRS - Gh Research Plc Latest Stock News & Market Updates  Stock Titan

GHRS - Gh Research Plc Latest Stock News & Market Updates - Stock Titan

Click here to get full coverage on GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression - Psychedelic Alpha

GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression  Psychedelic Alpha

GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression - Psychedelic Alpha

Click here to get full coverage on Hubble's Instruments: GHRS - Goddard High Resolution Spectrograph - ESA/Hubble

Hubble's Instruments: GHRS - Goddard High Resolution Spectrograph  ESA/Hubble

Hubble's Instruments: GHRS - Goddard High Resolution Spectrograph - ESA/Hubble

Click here to get full coverage on GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - GlobeNewswire

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer  GlobeNewswire

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - GlobeNewswire

Click here to get full coverage on GH Research PLC Announces Pricing of Initial Public Offering - PR Newswire

GH Research PLC Announces Pricing of Initial Public Offering  PR Newswire

GH Research PLC Announces Pricing of Initial Public Offering - PR Newswire

Click here to get full coverage on The 3 Best Psychedelic Stocks to Buy Now - InvestorPlace

The 3 Best Psychedelic Stocks to Buy Now  InvestorPlace

The 3 Best Psychedelic Stocks to Buy Now - InvestorPlace

Click here to get full coverage on GH Research: Can 'Toad Venom' Cure Depression? This Company Thinks It Can (NASDAQ:GHRS) - Seeking Alpha

GH Research: Can 'Toad Venom' Cure Depression? This Company Thinks It Can (NASDAQ:GHRS)  Seeking Alpha

GH Research: Can 'Toad Venom' Cure Depression? This Company Thinks It Can (NASDAQ:GHRS) - Seeking Alpha

Click here to get full coverage on 7 Psychedelics Stocks to Buy for a Big Drug Boom - InvestorPlace

7 Psychedelics Stocks to Buy for a Big Drug Boom  InvestorPlace

7 Psychedelics Stocks to Buy for a Big Drug Boom - InvestorPlace

Click here to get full coverage on 3 Psychedelic Stocks to Ride to the Moon and Beyond - Yahoo Finance

3 Psychedelic Stocks to Ride to the Moon and Beyond  Yahoo Finance

3 Psychedelic Stocks to Ride to the Moon and Beyond - Yahoo Finance

Click here to get full coverage on Global HR Services at Petronas - Trailblazing Talent Transformation - SSON

Global HR Services at Petronas - Trailblazing Talent Transformation  SSON

Global HR Services at Petronas - Trailblazing Talent Transformation - SSON

Click here to get full coverage on GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - The Lewiston Tribune

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer  The Lewiston Tribune

GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer - The Lewiston Tribune

Click here to get full coverage on 10 Best Psychedelic Stocks to Buy According to Hedge Funds - Yahoo Finance

10 Best Psychedelic Stocks to Buy According to Hedge Funds  Yahoo Finance

GHRS

Price Chart

Key Statistics

Technicals

About GHRS

Latest News

Why (GHRS) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - Yahoo Finance

Shorts Report: Why GHRS stock is favored by top institutions - Trade Risk Assessment & Safe Entry Point Alerts - moha.gov.vn

Advanced Charts

Top Gainers

Top Losers